University of Maryland School of Medicine researchers engineered a breakthrough protein therapy that acts as a fast, selective antidote for carbon monoxide (CO) poisoning. Published in PNAS, the molecule outperforms existing candidates by rapidly removing CO from the bloodstream with fewer side effects. This advance has potential to transform emergency treatment paradigms for CO poisoning, a leading cause of accidental poisoning mortality worldwide.